These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18855532)

  • 21. Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients.
    Yasui-Furukori N; Saito M; Tsuchimine S; Nakagami T; Sato Y; Sugawara N; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1491-5. PubMed ID: 18579277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Genetic Variants of Dopamine and Serotonin In Schizophrenia.
    Zakharyan R; Ghazaryan H; Kocourkova L; Chavushyan A; Mkrtchyan A; Zizkova V; Arakelyan A; Petrek M
    Arch Med Res; 2020 Jan; 51(1):13-20. PubMed ID: 32086104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.
    Gupta M; Bhatnagar P; Grover S; Kaur H; Baghel R; Bhasin Y; Chauhan C; Verma B; Manduva V; Mukherjee O; Purushottam M; Sharma A; Jain S; Brahmachari SK; Kukreti R
    Pharmacogenomics; 2009 Mar; 10(3):385-97. PubMed ID: 19290789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between a polymorphism of the HTR3A gene and therapeutic response to risperidone treatment in drug-naive Chinese schizophrenia patients.
    Gu B; Wang L; Zhang AP; Ma G; Zhao XZ; Li HF; Feng GY; He L; Xing QH
    Pharmacogenet Genomics; 2008 Aug; 18(8):721-7. PubMed ID: 18622264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia.
    Mössner R; Schuhmacher A; Kühn KU; Cvetanovska G; Rujescu D; Zill P; Quednow BB; Rietschel M; Wölwer W; Gaebel W; Wagner M; Maier W
    Pharmacogenet Genomics; 2009 Jan; 19(1):91-4. PubMed ID: 18849890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the dopamine D3 receptor (DRD3) gene polymorphisms on risperidone response: a pharmacogenetic study.
    Xuan J; Zhao X; He G; Yu L; Wang L; Tang W; Li X; Gu N; Feng G; Xing Q; He L
    Neuropsychopharmacology; 2008 Jan; 33(2):305-11. PubMed ID: 17429404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain.
    Müller DJ; Zai CC; Sicard M; Remington E; Souza RP; Tiwari AK; Hwang R; Likhodi O; Shaikh S; Freeman N; Arenovich T; Heinz A; Meltzer HY; Lieberman JA; Kennedy JL
    Pharmacogenomics J; 2012 Apr; 12(2):156-64. PubMed ID: 20714340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients.
    Xing Q; Qian X; Li H; Wong S; Wu S; Feng G; Duan S; Xu M; Gao R; Qin W; Gao J; Meng J; He L
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):631-7. PubMed ID: 17105675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics analysis of serotonin receptor gene variants and clinical response to risperidone in Han Chinese schizophrenic patients.
    Zhou W; Chang W; Yan Y; Shen L; Li W; Yi Z; Qin S
    Neurosci Lett; 2018 Sep; 683():202-206. PubMed ID: 30081060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relevance of CYP2D6 variability in first-episode schizophrenia patients treated with risperidone.
    Barteček R; Juřica J; Zrůstová J; Kašpárek T; Pindurová E; Žourková A
    Neuro Endocrinol Lett; 2012; 33(2):236-44. PubMed ID: 22592207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis.
    Sacchetti E; Magri C; Minelli A; Valsecchi P; Traversa M; Calza S; Vita A; Gennarelli M
    Pharmacogenomics J; 2017 Mar; 17(2):146-154. PubMed ID: 26856250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions.
    Correia CT; Almeida JP; Santos PE; Sequeira AF; Marques CE; Miguel TS; Abreu RL; Oliveira GG; Vicente AM
    Pharmacogenomics J; 2010 Oct; 10(5):418-30. PubMed ID: 19997080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients.
    Lencz T; Robinson DG; Xu K; Ekholm J; Sevy S; Gunduz-Bruce H; Woerner MG; Kane JM; Goldman D; Malhotra AK
    Am J Psychiatry; 2006 Mar; 163(3):529-31. PubMed ID: 16513877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine D3 receptor Ser9Gly polymorphism and risperidone response.
    Lane HY; Hsu SK; Liu YC; Chang YC; Huang CH; Chang WH
    J Clin Psychopharmacol; 2005 Feb; 25(1):6-11. PubMed ID: 15643094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of dopamine receptor D1 (DRD1) polymorphisms with risperidone treatment response in Chinese schizophrenia patients.
    Huo R; Wei Z; Xiong Y; Jiang J; Liu Y; Yan Y; Shi J; Li W; Cui D; Xing Q; He L; Qin S
    Neurosci Lett; 2015 Jan; 584():178-83. PubMed ID: 25179995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients.
    Xing Q; Gao R; Li H; Feng G; Xu M; Duan S; Meng J; Zhang A; Qin S; He L
    Pharmacogenomics; 2006 Oct; 7(7):987-93. PubMed ID: 17054409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia.
    Ikai S; Remington G; Suzuki T; Takeuchi H; Tsuboi T; Den R; Hirano J; Tsunoda K; Nishimoto M; Watanabe K; Mimura M; Mamo D; Uchida H
    J Clin Psychiatry; 2012 Aug; 73(8):1147-52. PubMed ID: 22967779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between a COMT polymorphism and clinical response to risperidone treatment: a pharmacogenetic study.
    Zhao QZ; Liu BC; Zhang J; Wang L; Li XW; Wang Y; Ji J; Yang FP; Wan CL; Xu YF; Feng GY; He L; He G
    Psychiatr Genet; 2012 Dec; 22(6):298-9. PubMed ID: 22935916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptom recurrence following intermittent treatment in first-episode schizophrenia successfully treated for 2 years: a 3-year open-label clinical study.
    Emsley R; Oosthuizen PP; Koen L; Niehaus DJ; Martinez G
    J Clin Psychiatry; 2012 Apr; 73(4):e541-7. PubMed ID: 22579160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of genetic correlates of response to Risperidone: Findings of a multicentric schizophrenia study from India.
    Kaur G; Gupta D; Chavan BS; Sinhmar V; Prasad R; Tripathi A; Garg PD; Gupta R; Khurana H; Gautam S; Margoob MA; Aneja J
    Asian J Psychiatr; 2017 Oct; 29():174-182. PubMed ID: 28692863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.